173 related articles for article (PubMed ID: 29713246)
1. Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.
Aveic S; Pantile M; Polo P; Sidarovich V; De Mariano M; Quattrone A; Longo L; Tonini GP
Cancer Cell Int; 2018; 18():63. PubMed ID: 29713246
[TBL] [Abstract][Full Text] [Related]
2. Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib.
Corallo D; Pastorino F; Pantile M; Mariotto E; Caicci F; Viola G; Ponzoni M; Tonini GP; Aveic S
J Exp Clin Cancer Res; 2020 Sep; 39(1):195. PubMed ID: 32962733
[TBL] [Abstract][Full Text] [Related]
3. Resistance to receptor tyrosine kinase inhibitors in solid tumors: can we improve the cancer fighting strategy by blocking autophagy?
Aveic S; Tonini GP
Cancer Cell Int; 2016; 16():62. PubMed ID: 27486382
[TBL] [Abstract][Full Text] [Related]
4. Receptor Tyrosine Kinase Phosphorylation Pattern-Based Multidrug Combination Is an Effective Approach for Personalized Cancer Treatment.
Sun X; Song Q; He L; Yan L; Liu J; Zhang Q; Yu Q
Mol Cancer Ther; 2016 Oct; 15(10):2508-2520. PubMed ID: 27458140
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of JNJ-26481585-mediated autophagy induces apoptosis via ROS activation and mitochondrial membrane potential disruption in neuroblastoma cells.
Kommalapati VK; Kumar D; Tangutur AD
Mol Cell Biochem; 2020 May; 468(1-2):21-34. PubMed ID: 32146648
[TBL] [Abstract][Full Text] [Related]
6. Retrospective comparison of triple-sequence therapies in metastatic renal cell carcinoma.
Busch J; Seidel C; Erber B; Issever AS; Hinz S; Kempkensteffen C; Magheli A; Miller K; Grünwald V; Weikert S
Eur Urol; 2013 Jul; 64(1):62-70. PubMed ID: 22999519
[TBL] [Abstract][Full Text] [Related]
7. Sequence therapy in patients with metastatic renal cell carcinoma: comparison of common targeted treatment options following failure of receptor tyrosine kinase inhibitors.
Busch J; Seidel C; Kempkensteffen C; Johannsen M; Wolff I; Hinz S; Magheli A; Miller K; Grünwald V; Weikert S
Eur Urol; 2011 Dec; 60(6):1163-70. PubMed ID: 21802830
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.
Bisping G; Wenning D; Kropff M; Gustavus D; Müller-Tidow C; Stelljes M; Munzert G; Hilberg F; Roth GJ; Stefanic M; Volpert S; Mesters RM; Berdel WE; Kienast J
Clin Cancer Res; 2009 Jan; 15(2):520-31. PubMed ID: 19147757
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.
Stalnecker CA; Grover KR; Edwards AC; Coleman MF; Yang R; DeLiberty JM; Papke B; Goodwin CM; Pierobon M; Petricoin EF; Gautam P; Wennerberg K; Cox AD; Der CJ; Hursting SD; Bryant KL
Cancer Res; 2022 Feb; 82(4):586-598. PubMed ID: 34921013
[TBL] [Abstract][Full Text] [Related]
10. Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells.
Aveic S; Pantile M; Seydel A; Esposito MR; Zanon C; Li G; Tonini GP
Oncotarget; 2016 Feb; 7(5):5646-63. PubMed ID: 26735175
[TBL] [Abstract][Full Text] [Related]
11. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP
Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647
[TBL] [Abstract][Full Text] [Related]
12. Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells.
Kang M; Lee KH; Lee HS; Jeong CW; Kwak C; Kim HH; Ku JH
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28165387
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models.
Cocco S; Leone A; Roca MS; Lombardi R; Piezzo M; Caputo R; Ciardiello C; Costantini S; Bruzzese F; Sisalli MJ; Budillon A; De Laurentiis M
J Transl Med; 2022 Jun; 20(1):290. PubMed ID: 35761360
[TBL] [Abstract][Full Text] [Related]
14. Palladium (II) Complex Enhances ROS-Dependent Apoptotic Effects via Autophagy Inhibition and Disruption of Multiple Signaling Pathways in Colorectal Cancer Cells.
Aydinlik S; Erkisa M; Ari F; Celikler S; Ulukaya E
Anticancer Agents Med Chem; 2021; 21(10):1284-1291. PubMed ID: 32990544
[TBL] [Abstract][Full Text] [Related]
15. c-Jun N-terminal kinase activation by nitrobenzoxadiazoles leads to late-stage autophagy inhibition.
Palumbo C; De Luca A; Rosato N; Forgione M; Rotili D; Caccuri AM
J Transl Med; 2016 Feb; 14():37. PubMed ID: 26847645
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines.
Del Grosso F; De Mariano M; Passoni L; Luksch R; Tonini GP; Longo L
BMC Cancer; 2011 Dec; 11():525. PubMed ID: 22192458
[TBL] [Abstract][Full Text] [Related]
17. The Autophagy Inhibitor Chloroquine, Alone or in Combination with mTOR Inhibitors, Displays Anti-Tumor Effects in In Vitro and In Vivo Lung Carcinoid Models.
Knigin A; Avniel-Polak S; Leibowitz G; Oleinikov K; Gross DJ; Grozinsky-Glasberg S
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944946
[TBL] [Abstract][Full Text] [Related]
18. Administration of Menadione, Vitamin K3, Ameliorates Off-Target Effects on Corneal Epithelial Wound Healing Due to Receptor Tyrosine Kinase Inhibition.
Rush JS; Bingaman DP; Chaney PG; Wax MB; Ceresa BP
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):5864-5871. PubMed ID: 27802516
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma.
Shao WQ; Zhu WW; Luo MJ; Fan MH; Li Q; Wang SH; Lin ZF; Zhao J; Zheng Y; Dong QZ; Lu L; Jia HL; Zhang JB; Lu M; Chen JH; Qin LX
Cell Rep; 2022 Apr; 39(3):110712. PubMed ID: 35443161
[TBL] [Abstract][Full Text] [Related]
20. Receptor tyrosine kinases and drug resistance: development and characterization of in vitro models of resistance to RTK inhibitors.
Corcoran C; O'Driscoll L
Methods Mol Biol; 2015; 1233():169-80. PubMed ID: 25319899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]